Viewing Study NCT07407166


Ignite Creation Date: 2026-03-26 @ 3:15 PM
Ignite Modification Date: 2026-03-26 @ 3:15 PM
Study NCT ID: NCT07407166
Status: RECRUITING
Last Update Posted: 2026-02-17
First Post: 2026-02-06
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Efficacy of First-Line Immunotherapy in Metastatic Melanoma in Slovenia and Identification of Predictive Biomarkers
Sponsor: Institute of Oncology Ljubljana
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module